Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study

被引:20
作者
Perris, Francesco [1 ]
Fabrazzo, Michele [1 ]
De Santis, Valeria [1 ]
Luciano, Mario [1 ]
Sampogna, Gaia [1 ]
Fiorillo, Andrea [1 ]
Catapano, Francesco [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Psychiat, Naples, Italy
来源
FRONTIERS IN PSYCHIATRY | 2019年 / 10卷
关键词
obsessive-compulsive disorder; personality disorders; comorbidity; serotonin reuptake inhibitors; antipsychotics; augmentation strategy; SEROTONIN REUPTAKE INHIBITORS; COGNITIVE-BEHAVIORAL THERAPY; SPECTRUM DISORDERS; PHARMACOLOGICAL-TREATMENT; INTERNATIONAL COLLEGE; MENTAL-DISORDERS; SCALE; OCD; FAMILY; RELIABILITY;
D O I
10.3389/fpsyt.2019.00386
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The present study aims to analyze the clinical and socio-demographic characteristics of patients with obsessive-compulsive disorder (OCD) in comorbidity with schizotypal personality disorder (SPD), as well as the response rate to pharmacological treatments. OCD+SPD patients had a younger age at onset, a higher probability to have more severe obsessive-compulsive symptoms, a higher rate of schizophrenia spectrum disorders in their first-degree relatives, and a poorer insight compared to OCD patients. During the 3-year follow-up period, these patients showed a lower rate of recovery, thus requiring augmentation with different psychotropic medications, including low doses of antipsychotics. Our findings suggest that the comorbidity of OCD and SPD causes a poor treatment response, and a reduced probability to recover using standard pharmacological treatment strategies. Further investigations are needed to identify alternative strategies, including psychoeducation and cognitive behavioral therapy, to manage such frequent comorbidity in clinical practice.
引用
收藏
页数:8
相关论文
共 46 条
  • [1] ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229
  • [2] [Anonymous], 1996, Structured Clinical Interview for DSM-IV Axis II Personality Disorders - (SCID-II), (Version 2.0)
  • [3] World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
    Bandelow, Borwin
    Zohar, Joseph
    Hollander, Eric
    Kasper, Siegfried
    Moeller, Hans-Juergen
    Allgulander, Christer
    Ayuso-Gutierrez, Jose
    Baldwin, David
    Bunevicius, Robertas
    Cassano, Giovanni
    Fineberg, Naomi
    Gabriels, Loes
    Hindmarch, Ian
    Kaiya, Hisanobu
    Klein, Donald F.
    Lader, Malcolm
    Lecrubier, Yves
    Lepine, Jean-Pierre
    Liebowitz, Michael R.
    Lopez-Ibor, Juan Jose
    Marazziti, Donatella
    Miguel, Euripedes C.
    Oh, Kang Seob
    Preter, Maurice
    Rupprecht, Rainer
    Sato, Mitsumoto
    Starcevic, Vladan
    Stein, Dan J.
    van Ameringen, Michael
    Vega, Johann
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2008, 9 (04) : 248 - 312
  • [4] Comorbidity, age of onset and suicidality in obsessive-Compulsive disorder (OCD): An international collaboration
    Brakoulias, V.
    Starcevic, V.
    Belloch, A.
    Brown, C.
    Ferrao, Y. A.
    Fontenelle, L. F.
    Lochner, C.
    Marazziti, D.
    Matsunaga, H.
    Miguel, E. C.
    Reddy, Y. C. J.
    do Rosario, M. C.
    Shavitt, R. G.
    Sundar, A. Shyam
    Stein, D. J.
    Torres, A. R.
    Viswasam, K.
    [J]. COMPREHENSIVE PSYCHIATRY, 2017, 76 : 79 - 86
  • [5] Obsessive-compulsive disorder: A 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study
    Catapano, Francesco
    Perris, Francesco
    Masella, Mariangela
    Rossano, Flavia
    Cigliano, Marco
    Magliano, Lorenza
    Maj, Mario
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2006, 40 (06) : 502 - 510
  • [6] Obsessive-compulsive disorder with poor insight: A three-year prospective study
    Catapano, Francesco
    Perris, Francesco
    Fabrazzo, Michele
    Cioffi, Valeria
    Giacco, Domenico
    De Santis, Valeria
    Maj, Mario
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (02) : 323 - 330
  • [7] The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)
    Dell'Osso, Bernardo
    Benatti, Beatrice
    Buoli, Massimiliano
    Altamura, A. Carlo
    Marazziti, Donatella
    Hollander, Eric
    Fineberg, Naomi
    Stein, Dan J.
    Pallanti, Stefano
    Nicolini, Humberto
    Van Ameringen, Michael
    Lochner, Christine
    Hranov, Georgi
    Karamustafalioglu, Oguz
    Hranov, Luchezar
    Menchon, Jose M.
    Zohar, Joseph
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (08) : 865 - 871
  • [8] The Brown Assessment of Beliefs Scale: Reliability and validity
    Eisen, JL
    Phillips, KA
    Baer, L
    Beer, DA
    Atala, KD
    Rasmussen, SA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (01) : 102 - 108
  • [9] Patterns of remission and relapse in obsessive-compulsive disorder: A 2-year prospective study
    Eisen, JL
    Goodman, WK
    Keller, MB
    Warshaw, MG
    DeMarco, LM
    Luce, DD
    Rasmussen, SA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (05) : 346 - 351
  • [10] The impact of a psychoeducational intervention on family members' views about schizophrenia: Results from the OASIS Italian multi-centre study
    Fiorillo, Andrea
    Bassi, Mariano
    de Girolamo, Giovanni
    Catapano, Francesco
    Romeo, Fabio
    [J]. INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2011, 57 (06) : 596 - 603